Back to search

Democritus University of Thrace (DUTH)

Ο ρόλος των ψυχολογικών χαρακτηριστικών (traits) Ελλήνων καπνιστών στην επιτυχημένη διακοπή καπνίσματος

Abstract

dc:description

The aim of the current study was to identify the role of psychological characteristics of treatment-seeking smokers and examine their role in cessation outcomes. Participants (Ν=750) were 558 heavily dependent, 168 moderate dependent and 24 light dependent smokers who were self-referred to an Outpatient Smoking Cessation Clinic. The sample was not demographically diverse; instead, it was a Greek Caucasian sample of smokers (52 % male, 48 % female, ±47 years, SD=11.4). The mean age of smoking initiation, i.e. age of first cigarette was 19.4 (SD=3.30) and the mean number of cigarettes consumed per day was 32.18 (SD=15.3). Data on smoking and psychological assessment was obtained from the Fagerström Test for Nicotine Dependence, the Satisfaction With Life Scale, the Self-Rating Zung Depression Scale, the Health Locus of Control Scale, the State-Trait Anxiety Inventory, the Coping Orientations to Problems Experienced Inventory, and the Eysenck Personality Inventory. Regarding medication treatment, a total of 635 (84.7 %) participants were prescribed Varenicline, 66 (8.8 %) received Nicotine Replacement Therapy (NRT), and 30 (4 %) wanted to quit without the use of medication. No criteria are available to assess which pharmacotherapy will prove most effective in a given patient. As a result, treatment decisions usually take into account the smoker’s history but also his/her preferred quit method. Varenicline was provided to the majority of the participants because it has been proven to be more effective in smoking cessation outcomes but also, because current research suggests that Varenicline use with minimal professional support appears to be more effective in achieving short-term abstinence. All forms of NRT also improve smoking cessation outcomes as it is evidenced by a recent Cochrane review that includes 150 trials of NRT, with over 50,000 people in the main analysis. Finally, duration of treatment varied from at least eight weeks for NRT (depending again on NRT products) to 12 weeks which is the recommended treatment duration for Varenicline. Participants were instructed to start NRT two weeks and Varenicline one week prior to targeted quit day.Data was analyzed using SPSS 20.0 and p-values less than 0.05 were considered statistically significant. The Pearson correlation coefficient was used for the assessment of linear relationships between continuous variables. Differences in demographic and smoking variables were compared to cessation at 6 months and at 12 months with t-tests for continuous variables and chi-square tests for categorical variables which was followed by odds ratio. Odds ratios with 95 % confidence intervals were calculated and reported with p-values. Independent samples t-tests were conducted for the comparison of smoking cessation groups regarding mean scores of STAI, SRDS, and HLC scale and scores of severity of nicotine withdrawal symptoms. Logistic regression modeling was carried out to evaluate associations between psychological characteristics and smoking cessation at 6 and 12 months while adjusting for demographic characteristics such as age and gender. Α stepwise modeling procedure was followed along the lines proposed by Homer to identify the independent predictors of smoking cessation. Independent variables with p<0.20 were entered into a multivariable logistic regression model in the first step. Variables with p<0.05 were kept in the final model. Cluster analysis was conducted and clustering variables (demographic, smoking, and psychological characteristics) were measured at baseline and were standardized to z-scores. Significant multivariate results were followed by univariate analysis of variance(ANOVA) and post hoc Tukey tests, which are suitable and reliable tests for multiple tests between may subsamples.Smoking status was made by self-report and abstinence was defined as “not a single puff of smoke during the last week”. The self-reported abstinence rate at six-month follow-up was 33.7 % versus 9.4 % in one-year follow-up. Nicotine dependence was found to be associated with the number of cigarettes smoked per day (r=.35, n=750, p<.000). Higher nicotine dependent male smokers were more likely to quit at 6 months [t (748) =2.56, p<.010]. FTND scores were associated with increased likelihood of a quit attempt (OR=0.86; 95 % CI: 0.80, 0.92). Gender was positively related only to 12 months cessation, increasing the odds of abstinence for female smokers by about 5 times (OR: 4.97, 95 %, CI: 3.15-7.84). No significant differences were found between medication and smoking cessation at both follow-ups. Our hypothesis that those smokers who would report at baseline, a number of quit attempts (χ 2 (3, n=750) =11.37, p<.010), high self-confidence (χ2 (2, n=750)=7.85, p<.020), and health reasons for quitting (χ2 (2, n=750) =7.01, p<.030) would quit successfully was confirmed through significant correlations at six-month cessation. Smokers who experienced nicotine withdrawal symptoms and reported difficulty concentrating (p<.049) were more likely to quit at the six-month follow-up. Regarding HLC, I-HLC was found to be associated with smoking cessation at six-month follow-up, t (750)=1.42, p<.020. The smoking, demographic, and behavioral/dependence variables associated withsmoking cessation at 6-month follow-up are summarized in Table 2. Smoking cessation at 12-months follow-up was associated with nicotine withdrawal symptoms and reported increased appetite or weight gain (p<.059), no alcohol consumption (OR: 1.82, 95 %, CI: 1.20–2.75), and trait-anxiety (t (750)=1.42, p<.040. Stepwise multivariate logistic regression was performed to investigate the predictors of smoking cessation in one model. In the regression model, we entered only the variables that were significantly associated with smoking cessation at both follow-ups. The final stepwise modeling procedure identified the following three variables as independent predictors of smoking cessation: past quit attempts r=.014, p<.050, (OR: .778, 95 %, CI: .317–1), current life satisfaction r=.000, p<.050, (OR: .319, 95 %, CI: .105–.971), and I-internal health locus of control r=.019, p<.050, (OR: 1.04, 95 %, CI: 1.00–1.08) while adjusting for baseline demographics. In continuous abstinence at 12 months follow-up, in both women and men, no psychological characteristic was involved in the model, and the only significant predictor of continuous abstinence was nicotine dependence. Because the results presented in this study suggest that smokers may vary in terms of their cessation outcomes, cluster analytic procedures were used in a preliminary effort to discover subtypes of smokers based on their smoking and psychological characteristics. The smoking and the psychological characteristics served as the clustering variables and the four cluster groups which emerged were: (1) smokers who had never quit, (2) smokers who had quit successfully at 6-month follow-up, (3) smokers who had quit successfully at 12-month follow-up, and (4) smokers who had quit from the beginning. A one-way between subjects ANOVA was conducted to compare the effect of smoking and psychological characteristics on the four groups that differed in terms of smoking cessation. Tukey’s HSD (“Honestly Significant Difference”) was performed after the ANOVA in order to determine which g The group of smokers who had quit successfully compared to the group of smokers who hadn’t quit at all differed significantly (p<.05) in the following smoking and psychological variables: life satisfaction [F(3,745)=6.66, p=0.000], DSM-IV5 nicotine withdrawal symptom [F(3,745)=3.44, p=0.016], and internal HLC [F(3,745)=3.62, p=0.013]. Post-hoc comparisons using the Tukey HSD showed that the group of smokers who had quit from the beginning and the group of smokers who hadn’t quit differed significantly at p<.05.roups differ from each other.We can conclude that the study of smokers’ psychological characteristics can have important research implications in clinical practice. Our findings provide useful information on the unique cultural norms and social influences of Greek smokers and suggest the urgent need in primary care settings to address psychological characteristics along with cultural differences in order to change the smoking culture and achieve successful smoking cessation outcomes. Future research should target the psychological profile of Greeks smokers as key treatment components in routine smoking cessation practice.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stefanidou, Aimilia-Elisavet
  • Στεφανίδου, Αιμιλία-Ελισάβετ

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35128

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stefanidou, Aimilia-Elisavet; Στεφανίδου, Αιμιλία-Ελισάβετ. Ο ρόλος των ψυχολογικών χαρακτηριστικών (traits) Ελλήνων καπνιστών στην επιτυχημένη διακοπή καπνίσματος. Democritus University of Thrace (DUTH), 2014. http://hdl.handle.net/10442/hedi/35128